Ottobock invests in NeuroTech company ONWARD® Medical
mehr
Storys zum Thema Medizin, Gesundheit
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...
mehrEvent Announcement: VIROFIGHT Hybrid Symposium
Ein Dokumentmehrmedac Gesellschaft für klinische Spezialpräparate mbH
medac: CDMO medac group at CPHI in Milan
CPHI 2024 CDMO medac group reflects on successful meetings with business partners at CPHI in Milan Medac CDMO group, a reliable partner in contract development and manufacturing, is pleased to report a series of productive and insightful meetings with both current and potential business partners during this year’s CPHI Congress in Milan, held from 8–10 ...
Ein DokumentmehrBetter Health Requires More Participation by Young People
Berlin/Gütersloh (ots) - At this year’s World Health Summit in Berlin, the WHO Youth Council presented its vision for healthier societies. The World Health Organization’s Youth Council is calling on policymakers to better leverage the potential of young people. The Bertelsmann Stiftung and major youth organizations support the initiative. Better involvement of and support for young people is essential to creating a ...
mehrPress Release: EMA accepts Marketing Authorization Applications for AVT03, a Proposed Denosumab Biosimilar
EMA accepts Marketing Authorization Applications for AVT03, a Proposed Denosumab Biosimilar - STADA announces EMA acceptance of Marketing Authorization Applications for AVT03, a proposed denosumab biosimilar to Prolia® (Bone Health) and Xgeva® (Oncology) - STADA holds marketing rights for AVT03 in Europe, as well ...
mehr
Extreme Rainfall Poses Health Risks
Extreme Rainfall Poses Health Risks An international study led by Helmholtz Munich investigates the health consequences of heavy rainfall events. Researchers analyzed the relationship between precipitation patterns and mortality rates at 645 locations across 34 countries from 1980 to 2020. The key finding: Extremely heavy rainfall, which occurs approximately every five years, significantly increases the risk of death, ...
mehrNorgine Announces Appointment of New CEO Janneke van der Kamp
London (ots/PRNewswire) - Norgine (the "Company"), a leading European specialty pharmaceutical company, has today announced the appointment of Janneke van der Kamp as its new Chief Executive Officer (CEO), effective from 1 January 2025. Current CEO, Chris Bath, has stepped down from his role effective immediately. This change in leadership will support and enhance the Company's mission of bringing transformative medicines ...
mehrSuccessful MDR Certification for AI Solution in Predicting Postoperative Complications – New Product Generation for Optimized Patient Safety
Berlin (ots) - x-cardiac, a leader in AI-based medical devices for the prediction of postoperative complications after cardiac surgery, is pleased to announce the successful MDR (Medical Device Regulation) certification of its new x-cardiac-platform. This certification introduces a completely new generation of ...
mehrGerman Federal Chancellor Scholz, WHO Director-General Dr Tedros and Bill Gates at the World Health Summit 2024 / The world's leading global health conference begins on October 13
Berlin (ots) - The financing of WHO, Germany's role in global health, antimicrobial resistance, Mpox, digitalization - topics like these are on the agenda of this year's World Health Summit from October 13-15 in Berlin. Leading international experts and decision-makers from all sectors will discuss strategies for a ...
mehrGrünenthal appoints Dr. Jan Adams as Chief Commercial Officer
mehrRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
mehr
Launch of canSERV Call for Service Provision – "Training the Next Generation of Cancer Researchers"
Ein DokumentmehrLaunch of canSERV Call for Service Provision, "Training the Next Generation of Cancer Researchers"
Ein Dokumentmehr- 2
Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.
Ein Dokumentmehr - 2
Record financing rounds at the Munich biotech hub
Ein Dokumentmehr - 6
Press Release - hubergroup is Cradle to Cradle certified for the fourth time in a row
Ein Dokumentmehr Bosch Healthcare Solutions GmbH
Near-patient PCR rapid test for whooping cough for Vivalytic by Bosch now available / World's first fully automated PCR test for detection of B. pertussis, B. parapertussis, B. holmesii
mehr
- 2
PM: DHL Logistics Trend Radar 7.0 beleuchtet neue Entwicklungen in Bereichen wie KI und Nachhaltigkeit / PR: DHL Logistics Trend Radar 7.0 unveils emerging AI trends and sustainable solutions
2 Dokumentemehr LAUDA DR. R. WOBSER GMBH & CO. KG
Dr. Ralf Hermann ends career at LAUDA
mehrcanSERV relaunches Open Call for Service Provision
Ein DokumentmehrPress release: STADA continues strong growth journey in the first half of 2024
Ein Dokumentmehr- 4
Ottobock in top form – a year full of highlights
mehr Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August ...
mehr
FitLine becomes Official Partner of the ATP Tour
mehrBayer Collaborates with PAPACKS to Co-create Alternative-to-Plastic Packaging for Consumer Health Products
mehrTechnische Universität München
Multi-purpose mucus - What mucins can do in medicine
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE What mucins can do in medicine Multi-purpose mucus They are in our eyes, on our tongues, and in our stomachs: Protective layers of mucus, a slime consisting primarily of mucins. These are molecules which bind water to form a natural lubricant. Researchers at the Technical University of Munich (TUM) use them to develop coatings for contact lenses and intubation tubes, healing ...
mehr- 3
Seminar on Echocardiography: TEE Masterclass – live stream from the operating theatres of Leipzig Heart Center
mehr - 4
The Governance Triangle: 'Democracy does not exist in a vacuum'
mehr Hellmann Calipar Healthcare Logistics opens a new distribution center in Dubai
mehr
Vorherige3456789101112Nächste